nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—HTR4—adrenal cortex—adrenal gland cancer	0.0652	0.119	CbGeAlD
Cisapride—HTR4—pituitary gland—adrenal gland cancer	0.0526	0.0962	CbGeAlD
Cisapride—HTR2A—sympathetic nervous system—adrenal gland cancer	0.0489	0.0893	CbGeAlD
Cisapride—HTR4—adrenal gland—adrenal gland cancer	0.047	0.0859	CbGeAlD
Cisapride—HTR2A—vein—adrenal gland cancer	0.0458	0.0836	CbGeAlD
Cisapride—CYP2C19—urine—adrenal gland cancer	0.042	0.0766	CbGeAlD
Cisapride—CYP1A2—urine—adrenal gland cancer	0.0343	0.0626	CbGeAlD
Cisapride—CYP2C9—urine—adrenal gland cancer	0.0325	0.0594	CbGeAlD
Cisapride—Gefitinib—EGFR—adrenal gland cancer	0.0275	0.767	CrCbGaD
Cisapride—HTR2A—urine—adrenal gland cancer	0.0268	0.0489	CbGeAlD
Cisapride—CYP3A4—urine—adrenal gland cancer	0.0248	0.0453	CbGeAlD
Cisapride—CYP2D6—urine—adrenal gland cancer	0.0244	0.0446	CbGeAlD
Cisapride—HTR2B—adrenal cortex—adrenal gland cancer	0.0133	0.0243	CbGeAlD
Cisapride—HTR2B—adrenal gland—adrenal gland cancer	0.00959	0.0175	CbGeAlD
Cisapride—KCNH2—cardiac atrium—adrenal gland cancer	0.00877	0.016	CbGeAlD
Cisapride—CYP2B6—adrenal cortex—adrenal gland cancer	0.0087	0.0159	CbGeAlD
Cisapride—DRD2—pituitary gland—adrenal gland cancer	0.0087	0.0159	CbGeAlD
Cisapride—KCNH2—pituitary gland—adrenal gland cancer	0.00857	0.0156	CbGeAlD
Cisapride—Gefitinib—ABCB1—adrenal gland cancer	0.00836	0.233	CrCbGaD
Cisapride—CYP2C8—pituitary gland—adrenal gland cancer	0.00784	0.0143	CbGeAlD
Cisapride—KCNH2—adrenal gland—adrenal gland cancer	0.00765	0.014	CbGeAlD
Cisapride—CYP2B6—gonad—adrenal gland cancer	0.00721	0.0132	CbGeAlD
Cisapride—CYP2B6—adrenal gland—adrenal gland cancer	0.00628	0.0115	CbGeAlD
Cisapride—HTR2A—gonad—adrenal gland cancer	0.00588	0.0107	CbGeAlD
Cisapride—HTR2A—pituitary gland—adrenal gland cancer	0.00574	0.0105	CbGeAlD
Cisapride—HTR2A—adrenal gland—adrenal gland cancer	0.00512	0.00936	CbGeAlD
Cisapride—HTR2C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000563	0.00135	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—IGF2—adrenal gland cancer	0.00056	0.00134	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000557	0.00134	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—GNAS—adrenal gland cancer	0.000555	0.00133	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000554	0.00133	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000549	0.00132	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—SDHB—adrenal gland cancer	0.000548	0.00132	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000541	0.0013	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.000535	0.00129	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000526	0.00126	CbGpPWpGaD
Cisapride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000524	0.00126	CbGpPWpGaD
Cisapride—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.000519	0.00125	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000512	0.00123	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000511	0.00123	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.000511	0.00123	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000506	0.00122	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000503	0.00121	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.0005	0.0012	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000499	0.0012	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000498	0.0012	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000497	0.00119	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000494	0.00119	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000491	0.00118	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000489	0.00117	CbGpPWpGaD
Cisapride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000485	0.00116	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—POMC—adrenal gland cancer	0.000484	0.00116	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—SDHD—adrenal gland cancer	0.000477	0.00115	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—RRM1—adrenal gland cancer	0.000477	0.00115	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TERT—adrenal gland cancer	0.000466	0.00112	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000464	0.00111	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—SDHB—adrenal gland cancer	0.000464	0.00111	CbGpPWpGaD
Cisapride—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000463	0.00111	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000457	0.0011	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000455	0.00109	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000452	0.00109	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000451	0.00108	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000447	0.00107	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000445	0.00107	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000444	0.00107	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—SDHD—adrenal gland cancer	0.000438	0.00105	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—RRM1—adrenal gland cancer	0.000438	0.00105	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000436	0.00105	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000429	0.00103	CbGpPWpGaD
Cisapride—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000426	0.00102	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000425	0.00102	CbGpPWpGaD
Cisapride—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000422	0.00101	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00042	0.00101	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000414	0.000994	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000407	0.000978	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000406	0.000974	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—BAD—adrenal gland cancer	0.000405	0.000973	CbGpPWpGaD
Cisapride—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000391	0.000939	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—POMC—adrenal gland cancer	0.00039	0.000937	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000386	0.000926	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000384	0.000922	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000381	0.000914	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000377	0.000906	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TSHR—adrenal gland cancer	0.000374	0.000899	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—POMC—adrenal gland cancer	0.000374	0.000897	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—BRAF—adrenal gland cancer	0.000369	0.000886	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000369	0.000885	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000367	0.000881	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000365	0.000876	CbGpPWpGaD
Cisapride—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.000361	0.000866	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000358	0.000858	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—MED12—adrenal gland cancer	0.000356	0.000854	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—SDHD—adrenal gland cancer	0.000353	0.000847	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—RRM1—adrenal gland cancer	0.000353	0.000847	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MEN1—adrenal gland cancer	0.000352	0.000845	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000348	0.000835	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—RRM1—adrenal gland cancer	0.000345	0.000828	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—SDHD—adrenal gland cancer	0.000345	0.000828	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	0.000344	0.000827	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000343	0.000823	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00034	0.000816	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.000339	0.000813	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000339	0.000813	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000327	0.000786	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—MED12—adrenal gland cancer	0.000326	0.000783	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000326	0.000782	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000324	0.000777	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.000323	0.000774	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000319	0.000765	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.000311	0.000747	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00031	0.000744	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	0.000306	0.000734	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000302	0.000726	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	0.000302	0.000725	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000299	0.000718	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—RRM1—adrenal gland cancer	0.000299	0.000717	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—SDHD—adrenal gland cancer	0.000299	0.000717	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000298	0.000714	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000297	0.000714	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000297	0.000713	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000294	0.000706	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000289	0.000694	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000284	0.000683	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000284	0.000682	CbGpPWpGaD
Cisapride—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000278	0.000668	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000275	0.000659	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000274	0.000657	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000273	0.000656	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00027	0.000649	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000269	0.000646	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000269	0.000645	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000267	0.00064	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000267	0.00064	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000267	0.00064	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	0.000267	0.00064	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—MED12—adrenal gland cancer	0.000263	0.000632	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000262	0.00063	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000262	0.00063	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	0.00026	0.000623	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000258	0.00062	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—MED12—adrenal gland cancer	0.000257	0.000618	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000254	0.000609	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000251	0.000602	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000249	0.000598	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000248	0.000596	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000247	0.000592	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000245	0.000589	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000245	0.000589	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000243	0.000584	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000243	0.000584	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	0.000238	0.000571	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000228	0.000547	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—MED12—adrenal gland cancer	0.000223	0.000535	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000221	0.000529	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	0.00022	0.000527	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000218	0.000523	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000217	0.00052	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000212	0.00051	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—EGFR—adrenal gland cancer	0.000211	0.000507	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GNAS—adrenal gland cancer	0.00021	0.000505	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.000208	0.000499	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.000208	0.000499	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	0.000206	0.000496	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.0002	0.000481	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000199	0.000478	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000199	0.000477	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000195	0.000467	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GNAS—adrenal gland cancer	0.000193	0.000463	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	0.000192	0.000461	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000191	0.00046	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000191	0.000459	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	0.000189	0.000454	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000188	0.000452	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.000188	0.000451	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000184	0.000441	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000183	0.000439	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	0.000183	0.000439	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000181	0.000435	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000178	0.000427	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TP53—adrenal gland cancer	0.000177	0.000426	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000177	0.000425	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000177	0.000424	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000176	0.000422	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000174	0.000417	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000171	0.000411	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	0.000163	0.00039	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000162	0.00039	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000162	0.000389	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.00016	0.000385	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.00016	0.000385	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.00016	0.000383	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	0.000159	0.000382	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000159	0.000381	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000156	0.000375	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GNAS—adrenal gland cancer	0.000156	0.000374	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000155	0.000372	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000155	0.000372	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000154	0.000369	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	0.000153	0.000367	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000153	0.000366	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.000152	0.000365	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000151	0.000363	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	0.000149	0.000358	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000149	0.000357	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000147	0.000354	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	0.000147	0.000352	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000145	0.000348	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000145	0.000348	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000142	0.00034	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—POMC—adrenal gland cancer	0.000142	0.00034	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.00014	0.000337	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000139	0.000333	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000133	0.00032	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000132	0.000318	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GNAS—adrenal gland cancer	0.000132	0.000316	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.00013	0.000312	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—POMC—adrenal gland cancer	0.00013	0.000312	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000129	0.00031	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	0.000129	0.00031	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000128	0.000308	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000128	0.000307	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.00012	0.000287	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.000118	0.000284	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000118	0.000282	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000117	0.00028	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000115	0.000277	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000113	0.000272	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000113	0.000272	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.000113	0.000271	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	0.000113	0.000271	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.000111	0.000267	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00011	0.000265	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000108	0.00026	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000107	0.000257	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000106	0.000255	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000105	0.000253	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—POMC—adrenal gland cancer	0.000105	0.000252	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000105	0.000251	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.000104	0.000251	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	0.000104	0.000249	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.000103	0.000247	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.000103	0.000247	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—POMC—adrenal gland cancer	0.000102	0.000246	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000101	0.000243	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	9.99e-05	0.00024	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	9.83e-05	0.000236	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GNAS—adrenal gland cancer	9.16e-05	0.00022	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	8.99e-05	0.000216	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—POMC—adrenal gland cancer	8.87e-05	0.000213	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	8.72e-05	0.000209	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	8.44e-05	0.000203	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	8.36e-05	0.000201	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	8.29e-05	0.000199	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	8.17e-05	0.000196	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—POMC—adrenal gland cancer	7.92e-05	0.00019	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	7.45e-05	0.000179	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.33e-05	0.000176	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—POMC—adrenal gland cancer	7.28e-05	0.000175	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—POMC—adrenal gland cancer	7.22e-05	0.000173	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	7.08e-05	0.00017	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GNAS—adrenal gland cancer	7.07e-05	0.00017	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	6.96e-05	0.000167	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	6.94e-05	0.000167	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	6.69e-05	0.000161	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	6.32e-05	0.000152	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—POMC—adrenal gland cancer	6.17e-05	0.000148	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	5.9e-05	0.000142	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	5.81e-05	0.000139	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	5.81e-05	0.000139	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	5.76e-05	0.000138	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	5.62e-05	0.000135	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—adrenal gland cancer	4.96e-05	0.000119	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	4.92e-05	0.000118	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	4.88e-05	0.000117	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.76e-05	0.000114	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.8e-05	9.12e-05	CbGpPWpGaD
